Published in J Virol on February 17, 2010
Intracellular trafficking of the amyloid β-protein precursor (APP) regulated by novel function of X11-like. PLoS One (2011) 0.88
Dengue Virus Uses a Non-Canonical Function of the Host GBF1-Arf-COPI System for Capsid Protein Accumulation on Lipid Droplets. Traffic (2015) 0.80
Influenza infection modulates vesicular trafficking and induces Golgi complex disruption. Virusdisease (2016) 0.75
Alternative autophagy, brefeldin A and viral trafficking pathways. Autophagy (2016) 0.75
Role of Coatomer Protein I in Virus Replication. J Virol Antivir Res (2012) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Rab proteins as membrane organizers. Nat Rev Mol Cell Biol (2001) 19.95
Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol (2004) 6.10
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A (2000) 5.30
GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J Cell Biol (1992) 4.34
Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell (1992) 3.82
Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus. J Biol Chem (1994) 3.71
Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol (2001) 3.41
The Rab GTPase family. Genome Biol (2001) 3.37
Vesicular release of ebola virus matrix protein VP40. Virology (2001) 3.03
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
The debate about transport in the Golgi--two sides of the same coin? Cell (2000) 2.33
The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J Cell Sci (2006) 2.21
A GDP-bound of rab1 inhibits protein export from the endoplasmic reticulum and transport between Golgi compartments. J Cell Biol (1994) 2.21
Rab1 and Ca2+ are required for the fusion of carrier vesicles mediating endoplasmic reticulum to Golgi transport. J Cell Biol (1994) 1.83
GBF1, a guanine nucleotide exchange factor for ADP-ribosylation factors, is localized to the cis-Golgi and involved in membrane association of the COPI coat. Traffic (2002) 1.59
ADP-ribosylation factor/COPI-dependent events at the endoplasmic reticulum-Golgi interface are regulated by the guanine nucleotide exchange factor GBF1. Mol Biol Cell (2003) 1.52
Rab1b interacts with GBF1 and modulates both ARF1 dynamics and COPI association. Mol Biol Cell (2007) 1.43
COPI recruitment is modulated by a Rab1b-dependent mechanism. Mol Biol Cell (2003) 1.42
Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe (2008) 1.31
Dissection of membrane dynamics of the ARF-guanine nucleotide exchange factor GBF1. Traffic (2005) 1.20
The evolving understanding of COPI vesicle formation. Nat Rev Mol Cell Biol (2009) 1.14
Active ADP-ribosylation factor-1 (ARF1) is required for mitotic Golgi fragmentation. J Biol Chem (2007) 1.04
On vesicle formation and tethering in the ER-Golgi shuttle. Curr Opin Cell Biol (2009) 0.95
Mapping of a region of Ebola virus VP40 that is important in the production of virus-like particles. J Infect Dis (2007) 0.93
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Gain-of-function experiments on H7N9. Science (2013) 3.67
Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80
Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57
Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A (2009) 2.04
Cellular factors required for Lassa virus budding. J Virol (2006) 2.02
Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol (2005) 1.97
The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol (2011) 1.95
High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis (2003) 1.89
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol (2003) 1.88
The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol (2012) 1.84
A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol (2011) 1.84
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proc Natl Acad Sci U S A (2013) 1.81
A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol (2007) 1.80
Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine (2003) 1.78
Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol (2003) 1.78
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A (2011) 1.73
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis (2008) 1.72
Pause on avian flu transmission studies. Nature (2012) 1.71
Influenza A (H5N1) viruses from pigs, Indonesia. Emerg Infect Dis (2010) 1.70
Functional mapping of the nucleoprotein of Ebola virus. J Virol (2006) 1.69
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog (2010) 1.65
H6 influenza viruses pose a potential threat to human health. J Virol (2014) 1.64
Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun (2012) 1.64
Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature (2010) 1.63
Assembly and budding of Ebolavirus. PLoS Pathog (2006) 1.62
Antibody-dependent enhancement of Ebola virus infection. J Virol (2003) 1.62
A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? J Gen Virol (2002) 1.60
Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell (2013) 1.59
Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A (2010) 1.56
Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology (2008) 1.55
Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J Virol (2008) 1.55
Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods (2010) 1.53